Efalizumab-induced subacute cutaneous lupus erythematosus.
Bentley
Danette D
DD
Graves
Julia E
JE
Smith
David I
DI
Heffernan
Michael P
MP
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D017676:Lichen Planus, Oral / Q000188:drug therapy; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab